Lonza Biologics Porriño SLU

About Lonza Biologics Porriño SLU

Lonza Biologics Porriño SLU is a leading contract development and manufacturing organization (CDMO) specializing in biologics. Located in the UK, the company is part of the global Lonza Group, which is renowned for its commitment to innovation and quality in the life sciences sector.

The facility in Porriño focuses on the production of monoclonal antibodies and other complex biologics, catering to the needs of pharmaceutical and biotechnology companies worldwide. With state-of-the-art technology and a highly skilled workforce, Lonza Biologics Porriño ensures that it meets the stringent regulatory requirements of the industry.

Lonza’s vision is to enable a healthier world by providing high-quality biopharmaceuticals that improve patient outcomes. The company is dedicated to sustainability and strives to minimize its environmental impact through efficient manufacturing processes.

Key services offered by Lonza Biologics Porriño include:

• Process Development: Tailored solutions for the development of robust manufacturing processes.
• Clinical Manufacturing: Scalable production capabilities for clinical trial materials.
• Commercial Manufacturing: Full-scale production to meet market demands.

With a strong emphasis on collaboration, Lonza Biologics Porriño partners with clients to accelerate their product development timelines and bring innovative therapies to market faster. The company’s commitment to excellence is reflected in its continuous investment in cutting-edge technologies and facilities.

In summary, Lonza Biologics Porriño SLU stands at the forefront of biopharmaceutical manufacturing, driven by a mission to support the healthcare industry with high-quality biologics that enhance the quality of life for patients globally.